Showing 81 - 100 of 533 results
Homepage
Eureka Prizes 2024
Nuclear Waste Solutions
Combining scientific expertise with more than $1.3 billion in unique operational assets to provide optimal radioactive waste solutions.
New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.
The 2021 ANSTO Australian Synchrotron Stephen Wilkins Medal
ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.
The 2023 ANSTO Australian Synchrotron Stephen Wilkins Medal
ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.
The 2022 ANSTO Australian Synchrotron Stephen Wilkins Medal
ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.
ANSTO User Meeting - Speakers
ANSTO User Meeting 2021 - Speakers
Australia and IAEA partnership launches new radiation oncology project to improve cancer patient outcomes in Asia and Pacific region
Australia launched a new international development project in partnership with the International Atomic Energy Agency (IAEA) to advance ‘Rays of Hope’ in the Asia and Pacific region.
Connecting bright STEM graduates with industries drives innovation
ANSTO, Australia’s knowledge centre for nuclear science and technology, connects STEM graduates with industry to work on real-world challenges through its FutureNow Scholarships for 2022.
ANSTO part of new network to transform Australia into world-leading space centre
ANSTO is a partner on the National Space Qualification Network (NSQN) led by the Australian National University (ANU) that will transform Australia into a world-leading space centre by enhancing facilities to test payloads, components, and hardware prior to their use in harsh environments of space.
Strategic research agreement
Strategic partnership with the University of Sydney expanded to continue a long history of research collaboration.
Scientific ingenuity at work
Contributing to research that strengthens the defence of Australia
ANSTO contributes to new understanding of how COVID infects humans
ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.
Statement of Intent
In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.
Role at ANSTO
Role at ANSTO
Access to instruments
Approximately 200 external users access the accelerators through the merit-based system, in-kind partnerships and pay for service arrangements,